(Q45521991)

14 December 2017

title

Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination (English)

1 reference

14 December 2017

1 reference

Gillian M Air

5

0 references

Wendy A Keitel

series ordinal

4

object named as

Wendy A Keitel

1 reference

14 December 2017

Upma Gulati

1

1 reference

14 December 2017

Kshama Kumari

series ordinal

2

1 reference

14 December 2017

Wenxin Wu

series ordinal

3

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

23

1 reference

14 December 2017

issue

11

1 reference

14 December 2017

page(s)

1414-1425

1 reference

Epitopes on protein antigens: misconceptions and realities.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Influenza virus infection of desialylated cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Selection and analysis of antigenic variants of the neuraminidase of N2 influenza viruses with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Expression of functional influenza virus A polymerase proteins and template from cloned cDNAS in recombinant vaccinia virus infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Cross-reaction but no avidity change of the serum antibody response after influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to alpha2,8-linked sialic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Human influenza virus recognition of sialyloligosaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

The role of antibody concentration and avidity in antiviral protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Mechanism of neutralization of influenza virus infectivity by antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Decreased antibody response among nursing home residents who received recalled influenza vaccine and results of revaccination, 1996-97.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Efficacy of Purified Influenza Subunit Vaccines and Relation to the Major Antigenic Determinants on the Hemagglutinin Molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Antibody response to whole-virus and split-virus influenza vaccines in successful ageing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and "original antigenic sin"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Variable efficacy of repeated annual influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

Mapping the antigenic and genetic evolution of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.053

10.1016/J.VACCINE.2004.08.053

7 January 2021

Identifiers

DOI

1 reference

14 December 2017

1 reference